By Topic

Doubling IT Innovation Spending: Laying the Foundation for IT-Enabled Business Process, Supply Chain, and Service Innovation in the Pharmaceutical Industry

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)
Asakiewicz, C. ; Wesley J. Howe Sch. of Technol. Manage., Stevens Inst. of Technol. Castle Point on Hudson, Hoboken, NJ, USA

This IT leaders within the pharmaceutical Industry are struggling to meet two critical challenges: dramatically improve the efficiency of IT and use that efficiency to drive business innovation. Over the last few years, Pfizer has been putting in place a rationalization methodology to dramatically reduce IT "life cycle" costs. This methodology, when coupled with effective governance and portfolio management, facilitates the rationalization of IT resources, infrastructure, applications, databases, and IT-enabled business processes. The methodology has been successfully applied on a global basis to increase IT efficiency and effectiveness, as well as significantly reduces IT costs. This paper discusses the development and application of the methodology, which was part of a multi-year effort that I led on the part of Pfizer's Global Business Technology organization. The effort resulted in a 30% reduction in IT support and maintenance expenses, a 75% reduction in service providers, a 50% reduction in the cost of global operations support, and a 50% reduction in the worldwide portfolio of applications and databases. The associated savings allowed Pfizer to double its level of investment in IT-enabled business innovation throughout its Worldwide Drug Development organization. For Pfizer, the methodology served as a catalyst for IT organizations to increase their efficiency and become more effective at leveraging information, improving business processes, and seeding IT-enabled business innovation. For the Industry, this work can serve as a roadmap for improving the efficiency of IT organizations and using that efficiency to drive IT-enabled business innovation across the enterprise.

Published in:

Management and Service Science, 2009. MASS '09. International Conference on

Date of Conference:

20-22 Sept. 2009